Access Pathway News Today

Infinitopes Precision Immunomics has raised millions of pounds in seed funding.

LONDON, May 03, 2024 (GLOBE NEWSWIRE) -- Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to...

LONDON, May 03, 2024 (GLOBE NEWSWIRE) -- Compass Pathways plc (NASDAQ:CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that it will

LONDON, May 02, 2024 -- Compass Pathways plc , a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, and Mindful Health Solutions , one of...

/PRNewswire/ -- Infinitopes Precision Immunomics, an integrated cancer biotech combining world leading platforms in precision antigen discovery with vaccine...

Funding also supports the start of phase I/IIa study for lead vaccine, ITOP1Oxford, UK (April 30th, 2024) – Infinitopes Precision Immunomics, an integrated cancer biotech combining world leading platforms in precision antigen discovery with vaccine vectors capable of durably stimulating protective immune...

LONDON, April 29, 2024 -- Compass Pathways plc , a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, and Journey Clinical, a leading...

While the UK is not short of life science start-up companies there is a disconnect when it comes to scaling up, with many choosing to relocate to other markets with perceived better opportunities, writes Sarah Brereton, Director at Limewash Media.

RAPIDe-3, a global pivotal Phase 3 study of deucrictibant for the on-demand treatment of HAE attacks, is currently enrollingEnd-of-Phase 2 meeting...

David Norton Assumes Role of Interim Board Chair while the Company Runs a Global Search for a New ChairLONDON, March 28, 2024 -- Compass Pathways plc , a biotechnology company dedicated to...